

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | short-term memory (GO:0007614) | 8.34660810 |
| 2 | cerebellar Purkinje cell layer development (GO:0021680) | 6.59374141 |
| 3 | cellular potassium ion homeostasis (GO:0030007) | 5.61486796 |
| 4 | L-amino acid import (GO:0043092) | 5.57500009 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.56878439 |
| 6 | C4-dicarboxylate transport (GO:0015740) | 5.26639934 |
| 7 | sodium ion export (GO:0071436) | 5.22229891 |
| 8 | metanephric nephron tubule development (GO:0072234) | 5.10801631 |
| 9 | metanephric tubule development (GO:0072170) | 5.10801631 |
| 10 | amino acid import (GO:0043090) | 5.02434555 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.90806951 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.89515771 |
| 13 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.79470775 |
| 14 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.76458039 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 4.68828066 |
| 16 | metanephric nephron epithelium development (GO:0072243) | 4.67163001 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.61743697 |
| 18 | cell communication by electrical coupling (GO:0010644) | 4.58641769 |
| 19 | collecting duct development (GO:0072044) | 4.58615528 |
| 20 | neurofilament cytoskeleton organization (GO:0060052) | 4.55906772 |
| 21 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 4.44077967 |
| 22 | positive regulation of muscle hypertrophy (GO:0014742) | 4.44077967 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.39287967 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.34198124 |
| 25 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.31505093 |
| 26 | glutamate secretion (GO:0014047) | 4.31035173 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.29253471 |
| 28 | metanephric epithelium development (GO:0072207) | 4.28264098 |
| 29 | response to auditory stimulus (GO:0010996) | 4.26541520 |
| 30 | multicellular organismal movement (GO:0050879) | 4.24655137 |
| 31 | musculoskeletal movement (GO:0050881) | 4.24655137 |
| 32 | alanine transport (GO:0032328) | 4.22974242 |
| 33 | regulation of beta-amyloid formation (GO:1902003) | 4.22093277 |
| 34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.19276664 |
| 35 | inositol phosphate-mediated signaling (GO:0048016) | 4.18072428 |
| 36 | vocalization behavior (GO:0071625) | 4.13842356 |
| 37 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.10382630 |
| 38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.08861990 |
| 39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.07377927 |
| 40 | relaxation of smooth muscle (GO:0044557) | 4.05992919 |
| 41 | potassium ion import (GO:0010107) | 4.03313207 |
| 42 | neurotransmitter secretion (GO:0007269) | 4.01370816 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.01217076 |
| 44 | cerebellar granule cell differentiation (GO:0021707) | 4.00355367 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.00063197 |
| 46 | negative regulation of astrocyte differentiation (GO:0048712) | 3.97593569 |
| 47 | auditory behavior (GO:0031223) | 3.96535461 |
| 48 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.96394111 |
| 49 | chemosensory behavior (GO:0007635) | 3.95555421 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.91104387 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.90650468 |
| 52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.86962752 |
| 53 | layer formation in cerebral cortex (GO:0021819) | 3.86328773 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.83160539 |
| 55 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.83095479 |
| 56 | retina layer formation (GO:0010842) | 3.78497943 |
| 57 | cellular sodium ion homeostasis (GO:0006883) | 3.77853233 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73088667 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.72366787 |
| 60 | neurotransmitter uptake (GO:0001504) | 3.71656914 |
| 61 | acidic amino acid transport (GO:0015800) | 3.69438823 |
| 62 | exploration behavior (GO:0035640) | 3.68638420 |
| 63 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.67481807 |
| 64 | potassium ion homeostasis (GO:0055075) | 3.66161232 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.64608828 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.64004226 |
| 67 | long-term memory (GO:0007616) | 3.63476318 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.62581805 |
| 69 | negative regulation of heart rate (GO:0010459) | 3.61889043 |
| 70 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.61523487 |
| 71 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.59808099 |
| 72 | relaxation of cardiac muscle (GO:0055119) | 3.58802948 |
| 73 | regulation of synaptic vesicle transport (GO:1902803) | 3.57813793 |
| 74 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.54960858 |
| 75 | innervation (GO:0060384) | 3.54489890 |
| 76 | neuron cell-cell adhesion (GO:0007158) | 3.53389475 |
| 77 | proline transport (GO:0015824) | 3.50919171 |
| 78 | regulation of postsynaptic membrane potential (GO:0060078) | 3.50826271 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.47360474 |
| 80 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.47169528 |
| 81 | membrane depolarization during action potential (GO:0086010) | 3.45921257 |
| 82 | retinal cone cell development (GO:0046549) | 3.45062873 |
| 83 | serotonin metabolic process (GO:0042428) | 3.44148301 |
| 84 | detection of calcium ion (GO:0005513) | 3.43720010 |
| 85 | aggressive behavior (GO:0002118) | 3.43369499 |
| 86 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.41139937 |
| 87 | neurotransmitter transport (GO:0006836) | 3.40020438 |
| 88 | L-glutamate transport (GO:0015813) | 3.39567984 |
| 89 | long term synaptic depression (GO:0060292) | 3.39414921 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36894865 |
| 91 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.35990386 |
| 92 | relaxation of muscle (GO:0090075) | 3.34865486 |
| 93 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.34647323 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 3.34117111 |
| 95 | sodium ion homeostasis (GO:0055078) | 3.32803439 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 3.31932284 |
| 97 | protein localization to synapse (GO:0035418) | 3.31633493 |
| 98 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.30868438 |
| 99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.30687179 |
| 100 | membrane depolarization (GO:0051899) | 3.30535483 |
| 101 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.28518391 |
| 102 | behavioral response to nicotine (GO:0035095) | 3.26914362 |
| 103 | neuromuscular process controlling posture (GO:0050884) | 3.25851927 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 3.25797708 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 3.25634814 |
| 106 | long-term synaptic potentiation (GO:0060291) | 3.24597857 |
| 107 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23799671 |
| 108 | neuromuscular process controlling balance (GO:0050885) | 3.21559695 |
| 109 | adult walking behavior (GO:0007628) | 3.20707326 |
| 110 | glycine transport (GO:0015816) | 3.19205162 |
| 111 | positive regulation of amino acid transport (GO:0051957) | 3.19205035 |
| 112 | glial cell proliferation (GO:0014009) | 3.18744314 |
| 113 | auditory receptor cell stereocilium organization (GO:0060088) | 3.16427049 |
| 114 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15460249 |
| 115 | mechanosensory behavior (GO:0007638) | 3.10628609 |
| 116 | postsynaptic membrane organization (GO:0001941) | 3.10609004 |
| 117 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.07348693 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 3.07228027 |
| 119 | membrane repolarization (GO:0086009) | 3.06329678 |
| 120 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05020451 |
| 121 | negative regulation of norepinephrine secretion (GO:0010700) | 3.04662281 |
| 122 | response to histamine (GO:0034776) | 3.03509026 |
| 123 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.03462473 |
| 124 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.00560633 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.99921611 |
| 126 | primary amino compound metabolic process (GO:1901160) | 2.99543892 |
| 127 | presynaptic membrane organization (GO:0097090) | 2.99531826 |
| 128 | regulation of neurotransmitter transport (GO:0051588) | 2.99229618 |
| 129 | regulation of synaptic plasticity (GO:0048167) | 2.95531153 |
| 130 | central nervous system myelination (GO:0022010) | 2.92422418 |
| 131 | axon ensheathment in central nervous system (GO:0032291) | 2.92422418 |
| 132 | dendrite morphogenesis (GO:0048813) | 2.92041941 |
| 133 | negative regulation of sodium ion transport (GO:0010766) | 2.90092920 |
| 134 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.88143912 |
| 135 | regulation of cellular amide metabolic process (GO:0034248) | 2.86948808 |
| 136 | chondroitin sulfate catabolic process (GO:0030207) | 2.86116407 |
| 137 | low-density lipoprotein particle remodeling (GO:0034374) | 2.84226844 |
| 138 | regulation of respiratory system process (GO:0044065) | 2.82602352 |
| 139 | regulation of neurotransmitter secretion (GO:0046928) | 2.82510829 |
| 140 | ovulation cycle (GO:0042698) | 2.80739211 |
| 141 | atrial cardiac muscle cell action potential (GO:0086014) | 2.80127438 |
| 142 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.80089550 |
| 143 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79732124 |
| 144 | dendritic spine morphogenesis (GO:0060997) | 2.79637128 |
| 145 | cell differentiation in hindbrain (GO:0021533) | 2.79253002 |
| 146 | regulation of membrane repolarization (GO:0060306) | 2.78133836 |
| 147 | regulation of vesicle fusion (GO:0031338) | 2.78094304 |
| 148 | positive regulation of membrane potential (GO:0045838) | 2.75278432 |
| 149 | positive regulation of potassium ion transport (GO:0043268) | 2.75099231 |
| 150 | prepulse inhibition (GO:0060134) | 2.74836109 |
| 151 | positive regulation of synaptic transmission (GO:0050806) | 2.73494439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.07501960 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.30812772 |
| 3 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.27485458 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12557230 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.05444771 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92224408 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.79923307 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78243300 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78243300 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.73514012 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.68936704 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68220392 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63770179 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59568860 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58880265 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.58143981 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53215119 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.51542417 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51067238 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49146534 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.33956749 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33089784 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31905196 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25303554 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19483954 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16053148 |
| 27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.03786479 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00694687 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.94454205 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.90327367 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79260809 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74912133 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71994921 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57951677 |
| 35 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43390376 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41898622 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41707354 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40729561 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40032304 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39994940 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39309391 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37458699 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37424340 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35683148 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34972647 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33415066 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31418868 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31038504 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29835767 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27767436 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26649007 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24214399 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.22447143 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22389510 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22349598 |
| 56 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22307644 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22089223 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21554489 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19451885 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18216309 |
| 61 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17117807 |
| 62 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.16667861 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16151752 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15756781 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15752820 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15416812 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14165697 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13843513 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12758516 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12469124 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12273957 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11324700 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10190626 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06840100 |
| 75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06731978 |
| 76 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06211573 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04944454 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04319481 |
| 79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03550028 |
| 80 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03272824 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03068226 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01286301 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01225816 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00436150 |
| 85 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00061612 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99696644 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98622059 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97645381 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97116442 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96513774 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96249290 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95198912 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94900294 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94193744 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94094324 |
| 96 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93957646 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93268060 |
| 98 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93086360 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92028706 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91966080 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91545812 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90696516 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89676793 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88796113 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88509452 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88218107 |
| 107 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.87920459 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 0.87663440 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87394379 |
| 110 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86416432 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86003162 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85098631 |
| 113 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85063523 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84927667 |
| 115 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84913126 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83500070 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83169492 |
| 118 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.82406270 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82084323 |
| 120 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81633840 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81133397 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80992252 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80902658 |
| 124 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79704535 |
| 125 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79407377 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78881718 |
| 127 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.77511908 |
| 128 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.77028294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.31319584 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.63203968 |
| 3 | MP0009046_muscle_twitch | 3.43982606 |
| 4 | MP0003880_abnormal_central_pattern | 3.25849463 |
| 5 | MP0010386_abnormal_urinary_bladder | 3.24297565 |
| 6 | MP0009745_abnormal_behavioral_response | 3.05843259 |
| 7 | MP0002064_seizures | 2.98784848 |
| 8 | MP0003329_amyloid_beta_deposits | 2.94300146 |
| 9 | MP0001486_abnormal_startle_reflex | 2.87718103 |
| 10 | MP0003690_abnormal_glial_cell | 2.82356850 |
| 11 | MP0004270_analgesia | 2.81372603 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.79045402 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.78035007 |
| 14 | MP0004858_abnormal_nervous_system | 2.75873807 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.71791264 |
| 16 | MP0004885_abnormal_endolymph | 2.60510923 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 2.59060969 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.58028935 |
| 19 | MP0008569_lethality_at_weaning | 2.52747876 |
| 20 | MP0002272_abnormal_nervous_system | 2.43263443 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.32042220 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.26625171 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.26331988 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.13856690 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.06096238 |
| 26 | MP0001502_abnormal_circadian_rhythm | 2.02941431 |
| 27 | MP0002736_abnormal_nociception_after | 1.99192235 |
| 28 | MP0001984_abnormal_olfaction | 1.98893057 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.95699807 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.92933932 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.82548318 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.76653504 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76438765 |
| 34 | MP0003633_abnormal_nervous_system | 1.71720544 |
| 35 | MP0001970_abnormal_pain_threshold | 1.71478308 |
| 36 | MP0002254_reproductive_system_inflammat | 1.61086289 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.59966513 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.56378809 |
| 39 | MP0003075_altered_response_to | 1.55764097 |
| 40 | MP0004924_abnormal_behavior | 1.54759414 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.54759414 |
| 42 | MP0004142_abnormal_muscle_tone | 1.53341317 |
| 43 | MP0003631_nervous_system_phenotype | 1.52186555 |
| 44 | MP0000778_abnormal_nervous_system | 1.51381088 |
| 45 | MP0002822_catalepsy | 1.50759617 |
| 46 | MP0003634_abnormal_glial_cell | 1.50040078 |
| 47 | MP0000604_amyloidosis | 1.49730087 |
| 48 | MP0003787_abnormal_imprinting | 1.44412883 |
| 49 | MP0003632_abnormal_nervous_system | 1.44009042 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.38696075 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.37787165 |
| 52 | MP0000955_abnormal_spinal_cord | 1.37480195 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.37249655 |
| 54 | MP0001485_abnormal_pinna_reflex | 1.35446771 |
| 55 | MP0002184_abnormal_innervation | 1.34159909 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.33252360 |
| 57 | MP0003122_maternal_imprinting | 1.19822986 |
| 58 | MP0004484_altered_response_of | 1.19620262 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.16098308 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.13498361 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.10990069 |
| 62 | MP0003878_abnormal_ear_physiology | 1.10990069 |
| 63 | MP0002090_abnormal_vision | 1.09188409 |
| 64 | MP0002152_abnormal_brain_morphology | 1.08214559 |
| 65 | MP0002229_neurodegeneration | 1.07978977 |
| 66 | MP0000920_abnormal_myelination | 1.07486563 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.06390659 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.05591052 |
| 69 | MP0001905_abnormal_dopamine_level | 1.04911794 |
| 70 | MP0001963_abnormal_hearing_physiology | 1.02387925 |
| 71 | MP0003137_abnormal_impulse_conducting | 1.01257050 |
| 72 | MP0004742_abnormal_vestibular_system | 1.00856080 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.00736744 |
| 74 | MP0008872_abnormal_physiological_respon | 0.98995790 |
| 75 | MP0009384_cardiac_valve_regurgitation | 0.98311272 |
| 76 | MP0005253_abnormal_eye_physiology | 0.97612128 |
| 77 | MP0003123_paternal_imprinting | 0.91344547 |
| 78 | MP0003011_delayed_dark_adaptation | 0.91120465 |
| 79 | MP0003136_yellow_coat_color | 0.90837803 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 0.87917615 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.86768546 |
| 82 | MP0004147_increased_porphyrin_level | 0.86218605 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.85821268 |
| 84 | MP0000566_synostosis | 0.84667427 |
| 85 | MP0006276_abnormal_autonomic_nervous | 0.84147089 |
| 86 | MP0003879_abnormal_hair_cell | 0.83713498 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.81286992 |
| 88 | MP0005499_abnormal_olfactory_system | 0.81091879 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.81091879 |
| 90 | MP0005620_abnormal_muscle_contractility | 0.80560978 |
| 91 | MP0004043_abnormal_pH_regulation | 0.80191067 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.78593359 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.78048172 |
| 94 | MP0001177_atelectasis | 0.76410117 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.76209625 |
| 96 | MP0000751_myopathy | 0.75426413 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.75172011 |
| 98 | MP0005410_abnormal_fertilization | 0.74935079 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.74513255 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.74365769 |
| 101 | MP0003279_aneurysm | 0.74351999 |
| 102 | MP0000026_abnormal_inner_ear | 0.73496773 |
| 103 | MP0008877_abnormal_DNA_methylation | 0.72797591 |
| 104 | MP0001853_heart_inflammation | 0.71210339 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.70765525 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.70569864 |
| 107 | MP0005535_abnormal_body_temperature | 0.70346716 |
| 108 | MP0001529_abnormal_vocalization | 0.69562284 |
| 109 | MP0008874_decreased_physiological_sensi | 0.68818946 |
| 110 | MP0001188_hyperpigmentation | 0.68403877 |
| 111 | MP0000358_abnormal_cell_content/ | 0.67887761 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.64160984 |
| 113 | MP0005171_absent_coat_pigmentation | 0.63940056 |
| 114 | MP0004085_abnormal_heartbeat | 0.60285551 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.59443976 |
| 116 | MP0005166_decreased_susceptibility_to | 0.58986221 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.58723325 |
| 118 | MP0009840_abnormal_foam_cell | 0.57100316 |
| 119 | MP0003956_abnormal_body_size | 0.52098791 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.49655991 |
| 121 | MP0002083_premature_death | 0.47173676 |
| 122 | MP0010769_abnormal_survival | 0.46552347 |
| 123 | MP0002082_postnatal_lethality | 0.45347245 |
| 124 | MP0010770_preweaning_lethality | 0.45347245 |
| 125 | MP0003868_abnormal_feces_composition | 0.44908538 |
| 126 | MP0009379_abnormal_foot_pigmentation | 0.44866657 |
| 127 | MP0010768_mortality/aging | 0.44796053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.88823784 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 5.88823784 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 5.88823784 |
| 4 | Focal motor seizures (HP:0011153) | 5.71426667 |
| 5 | Megalencephaly (HP:0001355) | 5.41824897 |
| 6 | Myokymia (HP:0002411) | 5.38914059 |
| 7 | Horizontal nystagmus (HP:0000666) | 5.27926001 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.62106025 |
| 9 | Action tremor (HP:0002345) | 4.53388949 |
| 10 | Hemiplegia (HP:0002301) | 4.43804348 |
| 11 | Hemiparesis (HP:0001269) | 4.37652616 |
| 12 | Abnormality of binocular vision (HP:0011514) | 4.36864580 |
| 13 | Diplopia (HP:0000651) | 4.36864580 |
| 14 | Neurofibrillary tangles (HP:0002185) | 4.33425659 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.28208188 |
| 16 | Focal seizures (HP:0007359) | 4.19946030 |
| 17 | Visual hallucinations (HP:0002367) | 4.08091563 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.75894766 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.63864577 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.52787162 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.52787162 |
| 22 | Cerebral inclusion bodies (HP:0100314) | 3.30351925 |
| 23 | Febrile seizures (HP:0002373) | 3.29367404 |
| 24 | Atonic seizures (HP:0010819) | 3.25125711 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.22037541 |
| 26 | Status epilepticus (HP:0002133) | 3.19591859 |
| 27 | Abnormality of the corticospinal tract (HP:0002492) | 3.15901828 |
| 28 | Truncal ataxia (HP:0002078) | 3.12859855 |
| 29 | Postural instability (HP:0002172) | 3.12017434 |
| 30 | Abnormal eating behavior (HP:0100738) | 2.98651912 |
| 31 | Absence seizures (HP:0002121) | 2.97571781 |
| 32 | Clumsiness (HP:0002312) | 2.97421161 |
| 33 | Dysmetria (HP:0001310) | 2.94944752 |
| 34 | Intention tremor (HP:0002080) | 2.90671255 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 2.89222538 |
| 36 | Depression (HP:0000716) | 2.85806222 |
| 37 | Scanning speech (HP:0002168) | 2.76991897 |
| 38 | Dialeptic seizures (HP:0011146) | 2.74706887 |
| 39 | Anxiety (HP:0000739) | 2.72831232 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 2.66734300 |
| 41 | Impaired smooth pursuit (HP:0007772) | 2.48887158 |
| 42 | Ankle clonus (HP:0011448) | 2.48406197 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.48188789 |
| 44 | Hypoplastic left heart (HP:0004383) | 2.47675421 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.47534645 |
| 46 | Abnormality of the axillary hair (HP:0100134) | 2.47325681 |
| 47 | Abnormality of secondary sexual hair (HP:0009888) | 2.47325681 |
| 48 | Hyperventilation (HP:0002883) | 2.45078676 |
| 49 | Split foot (HP:0001839) | 2.43997654 |
| 50 | Narrow nasal bridge (HP:0000446) | 2.42986637 |
| 51 | Broad-based gait (HP:0002136) | 2.42279111 |
| 52 | Mixed hearing impairment (HP:0000410) | 2.40772959 |
| 53 | Tetraplegia (HP:0002445) | 2.39463687 |
| 54 | Genetic anticipation (HP:0003743) | 2.39309930 |
| 55 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.38752609 |
| 56 | Abnormality of glycolysis (HP:0004366) | 2.33960590 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.29744373 |
| 58 | Limb ataxia (HP:0002070) | 2.26463876 |
| 59 | Amblyopia (HP:0000646) | 2.23223356 |
| 60 | Humeroradial synostosis (HP:0003041) | 2.20305433 |
| 61 | Synostosis involving the elbow (HP:0003938) | 2.20305433 |
| 62 | Slow progression (HP:0003677) | 2.19707377 |
| 63 | Bradykinesia (HP:0002067) | 2.19558964 |
| 64 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17650937 |
| 65 | Poor eye contact (HP:0000817) | 2.17571651 |
| 66 | Rigidity (HP:0002063) | 2.15140354 |
| 67 | Autoamputation (HP:0001218) | 2.15092127 |
| 68 | Dysmetric saccades (HP:0000641) | 2.14002550 |
| 69 | Abnormality of saccadic eye movements (HP:0000570) | 2.12751021 |
| 70 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.12276150 |
| 71 | Cerebellar atrophy (HP:0001272) | 2.11705845 |
| 72 | Long nose (HP:0003189) | 2.11302805 |
| 73 | Acute encephalopathy (HP:0006846) | 2.09890338 |
| 74 | Impaired social interactions (HP:0000735) | 2.08649919 |
| 75 | Abnormal social behavior (HP:0012433) | 2.08649919 |
| 76 | Confusion (HP:0001289) | 2.05873700 |
| 77 | Pheochromocytoma (HP:0002666) | 2.04522523 |
| 78 | Insidious onset (HP:0003587) | 2.03575432 |
| 79 | Termporal pattern (HP:0011008) | 2.03575432 |
| 80 | Urinary urgency (HP:0000012) | 2.02441630 |
| 81 | Back pain (HP:0003418) | 2.01293402 |
| 82 | Polyphagia (HP:0002591) | 1.99787849 |
| 83 | Stereotypic behavior (HP:0000733) | 1.99655792 |
| 84 | Annular pancreas (HP:0001734) | 1.99318730 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 1.97183287 |
| 86 | Dysarthria (HP:0001260) | 1.96808193 |
| 87 | Gait ataxia (HP:0002066) | 1.96607043 |
| 88 | Postural tremor (HP:0002174) | 1.94508223 |
| 89 | Short hallux (HP:0010109) | 1.93412179 |
| 90 | Bronchomalacia (HP:0002780) | 1.92433761 |
| 91 | Spastic gait (HP:0002064) | 1.91476117 |
| 92 | Abnormality of the dental pulp (HP:0006479) | 1.89280598 |
| 93 | Mitochondrial inheritance (HP:0001427) | 1.89269521 |
| 94 | Pseudobulbar signs (HP:0002200) | 1.89227758 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.88744332 |
| 96 | Psychosis (HP:0000709) | 1.86298508 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86234207 |
| 98 | Lower limb muscle weakness (HP:0007340) | 1.86041513 |
| 99 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.85669349 |
| 100 | Spinal canal stenosis (HP:0003416) | 1.84028898 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 1.83741500 |
| 102 | Hypoplastic heart (HP:0001961) | 1.83583320 |
| 103 | Dementia (HP:0000726) | 1.82911596 |
| 104 | Hypsarrhythmia (HP:0002521) | 1.82013206 |
| 105 | Ventricular fibrillation (HP:0001663) | 1.81502276 |
| 106 | Severe global developmental delay (HP:0011344) | 1.81393224 |
| 107 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.78415170 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.74815100 |
| 109 | Adactyly (HP:0009776) | 1.73740028 |
| 110 | Excessive salivation (HP:0003781) | 1.73337665 |
| 111 | Drooling (HP:0002307) | 1.73337665 |
| 112 | Torticollis (HP:0000473) | 1.73017663 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.72624280 |
| 114 | Incomplete penetrance (HP:0003829) | 1.71940644 |
| 115 | Athetosis (HP:0002305) | 1.71609209 |
| 116 | Heart block (HP:0012722) | 1.69817992 |
| 117 | Leukodystrophy (HP:0002415) | 1.68765336 |
| 118 | Limb dystonia (HP:0002451) | 1.67724943 |
| 119 | Neuroendocrine neoplasm (HP:0100634) | 1.66715739 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.65383029 |
| 121 | Fibular aplasia (HP:0002990) | 1.63769121 |
| 122 | Focal dystonia (HP:0004373) | 1.63640459 |
| 123 | Mutism (HP:0002300) | 1.62954800 |
| 124 | Peripheral hypomyelination (HP:0007182) | 1.62651882 |
| 125 | Delusions (HP:0000746) | 1.62256114 |
| 126 | Cerebral hypomyelination (HP:0006808) | 1.61897929 |
| 127 | Heterochromia iridis (HP:0001100) | 1.60372546 |
| 128 | Sleep apnea (HP:0010535) | 1.55118918 |
| 129 | Esotropia (HP:0000565) | 1.52694816 |
| 130 | Cerebral edema (HP:0002181) | 1.52590953 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.50065459 |
| 132 | Cholecystitis (HP:0001082) | 1.50065459 |
| 133 | Syncope (HP:0001279) | 1.49108782 |
| 134 | Increased hepatocellular lipid droplets (HP:0006565) | 1.48681385 |
| 135 | Craniofacial dystonia (HP:0012179) | 1.46452797 |
| 136 | Degeneration of anterior horn cells (HP:0002398) | 1.46369228 |
| 137 | Abnormality of the anterior horn cell (HP:0006802) | 1.46369228 |
| 138 | Unsteady gait (HP:0002317) | 1.42378968 |
| 139 | Increased CSF lactate (HP:0002490) | 1.41420099 |
| 140 | Akinesia (HP:0002304) | 1.37520524 |
| 141 | Epidermoid cyst (HP:0200040) | 1.36029241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.34925377 |
| 2 | LMTK2 | 3.58978273 |
| 3 | NTRK3 | 3.53587231 |
| 4 | NTRK2 | 3.21302379 |
| 5 | PRKD3 | 2.94148071 |
| 6 | PHKG1 | 2.66842886 |
| 7 | PHKG2 | 2.66842886 |
| 8 | MAP3K9 | 2.58885550 |
| 9 | TNIK | 2.34213292 |
| 10 | MAP3K4 | 2.22796560 |
| 11 | MINK1 | 2.21362781 |
| 12 | MAP2K7 | 2.04094884 |
| 13 | CAMKK1 | 1.99244320 |
| 14 | MUSK | 1.99191763 |
| 15 | CASK | 1.97569655 |
| 16 | CSNK1G2 | 1.86372734 |
| 17 | TRIB3 | 1.82216095 |
| 18 | PAK6 | 1.77277282 |
| 19 | MARK1 | 1.77177410 |
| 20 | CSNK1G3 | 1.68066307 |
| 21 | CSNK1A1L | 1.67032809 |
| 22 | CAMKK2 | 1.66466724 |
| 23 | PINK1 | 1.64961611 |
| 24 | STK38 | 1.64883967 |
| 25 | SGK2 | 1.63212189 |
| 26 | SGK494 | 1.59762287 |
| 27 | SGK223 | 1.59762287 |
| 28 | MYLK | 1.58334249 |
| 29 | TTK | 1.57523537 |
| 30 | DAPK2 | 1.55099397 |
| 31 | PRPF4B | 1.49385123 |
| 32 | SGK3 | 1.41077062 |
| 33 | PRKCG | 1.39975617 |
| 34 | NTRK1 | 1.38226112 |
| 35 | PRKG2 | 1.37170534 |
| 36 | CDK5 | 1.36017174 |
| 37 | MAPK13 | 1.34354289 |
| 38 | KSR2 | 1.33130395 |
| 39 | MAP2K4 | 1.32619731 |
| 40 | RIPK1 | 1.25732852 |
| 41 | TYRO3 | 1.25337108 |
| 42 | TESK1 | 1.23700500 |
| 43 | CSNK1G1 | 1.23681165 |
| 44 | BRAF | 1.17323099 |
| 45 | MAP3K13 | 1.17009057 |
| 46 | CDK19 | 1.09846178 |
| 47 | RIPK4 | 1.06701639 |
| 48 | PTK6 | 1.02900978 |
| 49 | GRK5 | 1.00705398 |
| 50 | PRKCH | 1.00308566 |
| 51 | LATS2 | 0.99914753 |
| 52 | FES | 0.95814978 |
| 53 | LIMK1 | 0.93743561 |
| 54 | MAPK12 | 0.92377173 |
| 55 | WNK1 | 0.92123417 |
| 56 | DYRK1A | 0.91742685 |
| 57 | TNK2 | 0.89801132 |
| 58 | NEK6 | 0.89287566 |
| 59 | CAMK2A | 0.87812128 |
| 60 | SIK1 | 0.87676790 |
| 61 | CAMK1 | 0.86883669 |
| 62 | PLK2 | 0.86243320 |
| 63 | CDK15 | 0.83693741 |
| 64 | RAF1 | 0.82550668 |
| 65 | CDK18 | 0.81783735 |
| 66 | DAPK3 | 0.80589041 |
| 67 | UHMK1 | 0.76077222 |
| 68 | KSR1 | 0.75741517 |
| 69 | SGK1 | 0.73027977 |
| 70 | CAMK1G | 0.72487626 |
| 71 | SIK2 | 0.72227116 |
| 72 | CDC42BPA | 0.71886982 |
| 73 | CDK14 | 0.71373387 |
| 74 | CDK11A | 0.71153283 |
| 75 | PRKCE | 0.69982793 |
| 76 | OXSR1 | 0.69406891 |
| 77 | CAMK2G | 0.67592001 |
| 78 | MAP3K2 | 0.66978162 |
| 79 | RET | 0.66091592 |
| 80 | MAP3K12 | 0.65724598 |
| 81 | STK11 | 0.65494975 |
| 82 | PAK4 | 0.64723315 |
| 83 | MAPK7 | 0.63227909 |
| 84 | PAK3 | 0.62727049 |
| 85 | CSNK1A1 | 0.61392129 |
| 86 | PDPK1 | 0.61149213 |
| 87 | SCYL2 | 0.60525072 |
| 88 | PDK1 | 0.60194023 |
| 89 | ADRBK1 | 0.59574573 |
| 90 | BMX | 0.58889624 |
| 91 | CAMK2B | 0.57591140 |
| 92 | MAP3K11 | 0.56617446 |
| 93 | ROCK2 | 0.56431996 |
| 94 | PRKDC | 0.55724206 |
| 95 | RPS6KA3 | 0.55351023 |
| 96 | FGR | 0.52363530 |
| 97 | ALK | 0.50186897 |
| 98 | ARAF | 0.49976301 |
| 99 | MOS | 0.48836688 |
| 100 | CCNB1 | 0.47948702 |
| 101 | CAMK4 | 0.47104530 |
| 102 | TSSK6 | 0.46765276 |
| 103 | DAPK1 | 0.46256285 |
| 104 | MAPKAPK5 | 0.45877500 |
| 105 | PRKCA | 0.45693191 |
| 106 | CSNK1D | 0.45032167 |
| 107 | ROCK1 | 0.44824984 |
| 108 | CAMK2D | 0.44817600 |
| 109 | FGFR2 | 0.44323330 |
| 110 | PRKCB | 0.42230740 |
| 111 | MAP3K7 | 0.42182831 |
| 112 | DMPK | 0.41509996 |
| 113 | CSNK1E | 0.41010445 |
| 114 | PKN1 | 0.40842219 |
| 115 | MARK2 | 0.40493944 |
| 116 | PRKD2 | 0.40493696 |
| 117 | FYN | 0.40156661 |
| 118 | PRKACA | 0.40131778 |
| 119 | CDK3 | 0.38690843 |
| 120 | MAPK10 | 0.38150647 |
| 121 | PRKCZ | 0.37781915 |
| 122 | PNCK | 0.37234807 |
| 123 | PRKACG | 0.37176147 |
| 124 | MAP3K1 | 0.37088336 |
| 125 | PRKG1 | 0.36621391 |
| 126 | SRC | 0.35393190 |
| 127 | NEK1 | 0.35010084 |
| 128 | DDR2 | 0.34554426 |
| 129 | ILK | 0.31743221 |
| 130 | RPS6KB1 | 0.31573986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.17213298 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50870974 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.79799732 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.76675485 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61468055 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60646041 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51064951 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24642477 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.24325116 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.15082639 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.12612156 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.04483724 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04015545 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00653896 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92338566 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84401651 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72845931 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.60096392 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.59707992 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.53660280 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.49828846 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46426272 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46014707 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41742959 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.37678737 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37427761 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35945835 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33559141 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31750963 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19759127 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.19327336 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.18322770 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14643802 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14514204 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11300791 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07210093 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03769965 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.03645742 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.03597000 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.02426258 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02187128 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96511112 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96379257 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95279890 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95114098 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94533082 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94004229 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92440477 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92319738 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91757172 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90982871 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89961529 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86786218 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.81485783 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78381814 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78012410 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77318731 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75805820 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74909098 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73861508 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73620118 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72698411 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68190303 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.67781220 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67673335 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65717002 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63720212 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63354986 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62367904 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61754539 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61750319 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.60289250 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58137800 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56708190 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56073754 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55707111 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54344251 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54004760 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53543117 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.51374540 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50669520 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50230371 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48571884 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47812363 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46889489 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46622922 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45425440 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44038044 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43345081 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43036566 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40543640 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40204148 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39493076 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39235940 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.36920077 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36678705 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36367831 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36051049 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35797841 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35496072 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33385200 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32312822 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31626197 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31051290 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30768232 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29900572 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.29384734 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27160373 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.25619535 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25330223 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24517132 |
| 112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24198773 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23316065 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22061878 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.21951558 |
| 116 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.17127782 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16244750 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14674387 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13976576 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12140180 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.07506420 |

